Table 1 Baseline clinical characteristics of the patients
From: Prognostic markers of heart failure in patients undergoing peritoneal dialysis
Total, n | 29 |
|---|---|
Female, n (%) | 8 (27.6) |
Age (years) | 64.14 ± 14.42 |
BMI (kg/m2) | 23.60 ± 3.057 |
DM, n (%) | 11 (37.9) |
Nephrosclerosis, n (%) | 9 (31.0) |
PD duration (months) | 12.04 ± 7.589 |
D/P ratio | 0.7273 ± 0.2034 |
D/D ratio | 0.3769 ± 0.1324 |
Weekly Kt/V urea | 1.813 ± 0.4844 |
Weekly CCr (L/week/1.73m2) | 86.31 ± 36.00 |
Urine volume (mL/day) | 919.8 ± 383.3 |
ARB, n (%) | 22(75.9) |
Statin, n (%) | 13 (44.8) |
Diuretic (%) | 25 (86.2) |
Iron supplementation, n (%) | 6 (20.7) |
LAD (mm) | 37.83 ± 6.042 |
LVMI (g/m2) | 126.7 ± 34.14 |
EF (%) | 66.99 ± 9.917 |
E/e' | 14.98 ± 8.113 |
CI | 3.332 ± 0.7997 |